01 January 2005
The involvement of immunoregulatory T cells in the pathogenesis of Lichen Sclerosus
Henryk Tchórzewski, Helena Rotsztejn, Małgorzata Banasik, Przemysław Lewkowicz, Ewa GłowackaMed Sci Monit 2005; 11(1): CR39-43 :: ID: 13875
Abstract
Background: The pathogenesis of lichen sclerosus (LS) and the mechanism of involution of LS-affected tissues is controversial. Autoimmune factors are proposed as a cause of disease. The involvement of autoimmune T lymphocytes in the disease development and progression is considered.Material/Methods: The investigation included 41 woman divided into two groups: a study group and controls. In the study group were 22 vulvular LS patients.Nineteen healthy woman underwent plastic surgery of the same area and served as controls. We analyzed reactive oxygen intermediate (ROI) production by peripheral blood granulocytes, the production of IL-2, IL-5, IL-10, IL-12, and TNF-a cytokines by lymphocytes, and the activation of CD25, CD26, CD69, CD71, and HLA DR antigen expression. Results: An increase in CD4+CD25+ suppressor T cells together with a decrease in CD3+CD26+ activated lymphocytes paralleled an increase in IL-10 production by peripheral blood lymphocytes of the lichen sclerosus patients. Diminished ROI production by peripheral blood granulocytes of LS patients was observed after both receptor-dependent and –independent stimulation. Baseline increase in IL-12 and stimulated increases in IL-2, IL-5, IL-10, and TNF-a production by lymphocytes of LS patients were also observed. Conclusions: The involution of lichen sclerosus-affected tissues may be the suppressive effect exerted by CD4+CD25+suppressor T lymphocytes, the increase in IL-10 inhibitory cytokine production, and diminished granulocyte ROI production. Infl ammatory infi ltrates in the affected regions of the skin are characterized by a diminished number of CD3 lymphocytes bearing the CD26 molecule, which may be responsible for an autocrine defect in bioactive mediator degradation.
Keywords: Lichen Sclerosus et Atrophicus - immunology, Adolescent, Autoimmune Diseases - pathology, CD4-Positive T-Lymphocytes - metabolism, Cytokines - metabolism, Leukocyte Count, Lichen Sclerosus et Atrophicus - pathology, Neutrophils - immunology, Reactive Oxygen Species - metabolism, Receptors, Interleukin-2 - metabolism, T-Lymphocytes - immunology
561 10
Editorial
01 June 2023 : Editorial
Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic PreparednessDOI: 10.12659/MSM.941209
Med Sci Monit 2023; 29:e941209
In Press
07 Jun 2023 : Review article
Ultrasound-Guided Brachial Plexus Block by Costoclavicular Space Approach: A Narrative ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.939920
05 Jun 2023 : Clinical Research
Comparison of Texture and Color Enhancement Imaging with White Light Imaging in 52 Patients with Short-Segm...Med Sci Monit In Press; DOI: 10.12659/MSM.940249
05 Jun 2023 : Laboratory Research
Comparison of Composite Resin (Duo-Shade) Shade Guide with Vita Ceramic Shades Before and After Chemical an...Med Sci Monit In Press; DOI: 10.12659/MSM.940949
02 Jun 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952